All News2023
- Dec. 11, 2023 CorporateOlympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
-
Dec. 08, 2023
IRNotice Concerning New Business Alliance Between Olympus and Sony
- Dec. 07, 2023 CorporateVesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
-
Dec. 04, 2023
IRNotice Regarding Status of Share Repurchase
- Nov. 30, 2023 CorporateOlympus's Net-Zero Targets Approved by SBTi
- Nov. 10, 2023 MedicalOlympus Issues Voluntary Field Action to Remind Users of Warnings for Bronchoscopes Used with High-Frequency Therapy Equipment
- Nov. 09, 2023 IRSecond Quarter Financial Results
-
Nov. 09, 2023
IRNotice Concerning the Revision of Financial Forecast
-
Nov. 09, 2023
IRNotice Regarding Share Repurchase and Cancellation of Treasury Shares
-
Nov. 08, 2023
IRNotice Regarding Completion of Share Repurchase and Cancellation of Treasury Shares
- Nov. 06, 2023 MedicalOlympus Announces Launch of EVIS X1™ Endoscopy System in China
-
Nov. 02, 2023
IRNotice Regarding Status of Share Repurchase
- Oct. 31, 2023 CorporateOlympus and Terumo Announce Change in Form of Contract
- Oct. 28, 2023 MedicalOlympus Issues Request to Discontinue Use of UHI-4 Insufflator Unit, Except in Cases Where No Alternative is Available
- Oct. 20, 2023 IRPublished Integrated Report 2023
- Oct. 19, 2023 MedicalOlympus Announces Market Launch of EVIS X1™ Endoscopy System in the U.S.
-
Oct. 03, 2023
IRNotice Regarding Status of Share Repurchase
- Oct. 03, 2023 CorporateOlympus Names Dr. John de Csepel as Chief Medical Officer
-
Sep. 06, 2023
IRNotice of Discontinuation of the Manufacture and Sale of Veran Medical Technologies' Electromagnetic Navigation Systems and Posting of Other Expense
-
Sep. 04, 2023
IRNotice Regarding Status of Share Repurchase
- Aug. 21, 2023 CorporateAnnual update of Sustainability Page
- Aug. 09, 2023 IRFirst Quarter Financial Results
- Aug. 09, 2023 CorporateNotice of Stock Change of Olympus Terumo Biomaterials
-
Aug. 02, 2023
IRNotice Regarding Status of Share Repurchase
-
Jul. 25, 2023
IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
-
Jul. 25, 2023
IR(Updated) Notice Regarding Partial Correction to the “Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems”
- Jul. 20, 2023 CorporateOlympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
-
Jul. 04, 2023
IRNotice Regarding Status of Share Repurchase
- Jul. 04, 2023 CorporateOlympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
-
Jun. 28, 2023
IRNotice Regarding Partial Amendments to the Articles of Incorporation
-
Jun. 27, 2023
IRNotice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
-
Jun. 19, 2023
IR(Change of Disclosure Matters) Notice Regarding Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary)
-
Jun. 16, 2023
IRNotice of Absorption-type Merger with Olympus Digital System Design, a Wholly Owned Subsidiary (Simplified Merger/Short-form Merger)
-
Jun. 16, 2023
IROverview of Evaluation Results on the Effectiveness of the Board of Directors of Olympus
-
Jun. 14, 2023
IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit System
- Jun. 05, 2023 CorporateOlympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision
-
Jun. 02, 2023
IRNotice Regarding Status of Share Repurchase
- May. 29, 2023 CorporateOlympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
-
May. 17, 2023
IRNotice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit System
- May. 12, 2023 CorporateOlympus Outlines Core Priorities Behind Refreshed Medical Strategy
- May. 12, 2023 IRFinancial Results
-
May. 12, 2023
IRNotice Regarding Share Repurchase and Cancellation of Treasury Shares
-
May. 12, 2023
IRNotice Concerning Recording Gain on Transfer of Shares
- May. 08, 2023 MedicalOlympus Announces FDA Clearance of New Endoscopy System and Compatible Endoscopes
-
Apr. 03, 2023
IR(Progress of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business
- Apr. 03, 2023 CorporateOlympus Announces Changes to Executive Officer Positions
-
Mar. 29, 2023
IRNotice Concerning Change of Closing Date of Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business and Revision to Financial Forecasts
- Mar. 29, 2023 CorporateOlympus Selected for two consecutive years as a Supplier Engagement Leader 2022, the Highest Rating in the CDP Supplier Engagement Rating
- Mar. 01, 2023 CorporateOlympus Certified as a 2023 Sports Yell Company by the Japan Sports Agency
-
Feb. 24, 2023
IRNotice Regarding Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary)
- Feb. 24, 2023 CorporateOlympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd,
- Feb. 17, 2023 CorporateOlympus Donates for Turkey and Syria Earthquake Relief
- Feb. 10, 2023 IRThird Quarter Financial Results
-
Feb. 10, 2023
IRNotification for the Candidates for the Board of Directors
-
Jan. 20, 2023
IR(Change of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business
-
Jan. 18, 2023
IRNotice Regarding the Status and Completion of Stock Repurchase
-
Jan. 11, 2023
IRNotice Concerning the Arbitral Award involving Consolidated Subsidiaries
-
Jan. 06, 2023
IRNotice Regarding Status of Share Repurchase